Literature DB >> 31836381

Very late-onset limb-girdle muscular dystrophy type 2D: A milder form with a normal muscle biopsy.

Miguel Oliveira Santos1, Pedro Coelho2, Rafael Roque2, Isabel Conceição3.   

Abstract

Sarcoglycanopathies are a genetically heterogeneous group of autosomal recessive limb-girdle muscular dystrophies (LGMD) caused by mutations in sarcoglycan genes. We report a Portuguese patient with a very late-onset LGMD phenotype, whose muscle biopsy and immunostaining, in particular for α-sarcoglycan, were unrevealing. Muscle MRI showed a predominant, bilateral and symmetric involvement of the tight muscles and also, to a lesser extent, of the posterior compartment of lower legs muscles. Next generation sequencing (NGS) revealed a known homozygous c.850C > T (p.Arg284Cys) mutation in SGCA gene. Milder forms of α-sarcoglycanopathies could be a challenging diagnosis; particularly if muscle histopathology and α-sarcoglycan immunohistochemistry are unhelpful. NGS plays a crucial role not only for aiding in the establishment of a definite diagnosis, but also for expanding clinical presentations.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Limb-girdle muscular dystrophy type 2D; Next generation sequencing; α-Sarcoglycan immunohistochemistry; α-Sarcoglycanopathy

Year:  2019        PMID: 31836381     DOI: 10.1016/j.jocn.2019.12.003

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy.

Authors:  Jorge Alonso-Pérez; Lidia González-Quereda; Claudio Bruno; Chiara Panicucci; Afagh Alavi; Shahriar Nafissi; Yalda Nilipour; Edmar Zanoteli; Lucas Michielon de Augusto Isihi; Béla Melegh; Kinga Hadzsiev; Nuria Muelas; Juan J Vílchez; Mario Emilio Dourado; Naz Kadem; Gultekin Kutluk; Muhammad Umair; Muhammad Younus; Elena Pegorano; Luca Bello; Thomas O Crawford; Xavier Suárez-Calvet; Ana Töpf; Michela Guglieri; Chiara Marini-Bettolo; Pia Gallano; Volker Straub; Jordi Díaz-Manera
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.